A prospective study on drug utilization pattern of anti-diabetic drugs in rural areas of Islampur, India



Similar documents
COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

Medication Adherence Amongst Diabetic Patients in a Tertiary Healthcare Institution in Central Nigeria

Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.

Robert Okwemba, BSPHS, Pharm.D Philadelphia College of Pharmacy

THE IMPACT OF USING BLOOD SUGAR HOME MONITORING DEVICE TO CONTROL BLOOD SUGAR LEVEL IN DIABETIC PATIENTS

Diabetes mellitus. Lecture Outline

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides.

Glycemic Control of Type 2 Diabetes Mellitus

BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Disability Evaluation Under Social Security

Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach

Causes, incidence, and risk factors

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Scholars Research Library

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Kansas Behavioral Health Risk Bulletin

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours

1333 Plaza Blvd, Suite E, Central Point, OR *

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

Is Insulin Effecting Your Weight Loss and Your Health?

Diabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease

Lincoln Memorial University Department of Nursing Nursing 124/125 Spring Semester 2005

2. What Should Advocates Know About Diabetes? O

Prior Authorization Guideline

Cost variation analysis of Oral Hypoglycaemic agents available in Indian market: An Economic Perspective

Insulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types

IMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

Common Drug Review Patient Group Input Submissions

SHORT CLINICAL GUIDELINE SCOPE

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Diabetes mellitus 1 عبد هللا الزعبي. pharmacology. Shatha Khalil Shahwan. 1 P a g e

Type 1 Diabetes. Pennington Nutrition Series. Overview. About Insulin

X-Plain Hypoglycemia Reference Summary

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes

HUMULIN R REGULAR INSULIN HUMAN INJECTION, USP (rdna ORIGIN) 100 UNITS PER ML (U-100)

TREATMENT PATTERN AND GLYCEMIC CONTROL OF ORAL HYPOGLYCAEMIC DRUGS AMONG TYPE II DM PATIENTS IN ERITREA

SCHOOL DISTRICT #22 VERNON DIABETES POLICY

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

EFFIMET 1000 XR Metformin Hydrochloride extended release tablet

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

My Doctor Says I Need to Take Diabetes Pills and Insulin... What Do I Do Now? BD Getting Started. Combination Therapy

WHAT IS DIABETES MELLITUS? CAUSES AND CONSEQUENCES. Living your life as normal as possible

Section 5: Type 2 Diabetes

Diabetes. Emergency Checklists. From A Child in Your Care Has Diabetes. A Collection of Information. Copyright 2005 by Elisa Hendel, M.Ed.

I. Research Proposal. 1. Background

Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE

WHAT I NEED TO KNOW ABOUT MY BLOOD SUGAR

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council

Diabetes The Basics. What is Diabetes? How does sugar get into your cells? Type 1 diabetes. Type 2 diabetes. Why control Diabetes?

Updates for your practice March, Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes

written by Harvard Medical School Insulin Therapy Managing Your Diabetes

1.00 REGULATORY AUTHORITY

FORWARDHEALTH PRIOR AUTHORIZATION / PREFERRED DRUG LIST (PA/PDL) FOR HYPOGLYCEMICS, INSULIN LONG-ACTING

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

Diagnosis, classification and prevention of diabetes

External Insulin Pumps Corporate Medical Policy

Algorithms for Glycemic Management of Type 2 Diabetes

4. Does your PCT provide structured education programmes for people with type 2 diabetes?

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

Introduction. We hope this guide will aide you and your staff in creating a safe and supportive environment for your students challenged by diabetes.

The Background for the Diabetes Detection Model

Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief

Diabetes Questionnaire

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-

Dietfree-Good News for Diabetics

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

Deakin Research Online

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure

Adherence to insulin therapy at a tertiary care diabetes center in South India

INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?

Post-Transplant Diabetes: What Every Patient Needs to Know

DR. Trinh Thi Kim Hue

Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.

WHAT DOES DYSMETABOLIC SYNDROME MEAN?

A guidebook for people with diabetes

Management of Diabetes in the Elderly. Sylvia Shamanna Internal Medicine (R1)

The Family Library. Understanding Diabetes

QUESTION 3. HOW SHOULD THE DATA AND REPORTING BE INTERPRETED?

MEDICAL COVERAGE POLICY. SERVICE: Insulin Pump and Continuous Glucose Monitoring. PRIOR AUTHORIZATION: Required. POLICY:

Inhaled Corticosteroids and Diabetes Onset

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or

Jill Malcolm, Karen Moir

Abdulaziz Al-Subaie. Anfal Al-Shalwi

INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco

Transcription:

Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):33-37 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4 A prospective study on drug utilization pattern of anti-diabetic drugs in rural areas of Islampur, India Pratiksha Kasture, Shivani Kasture, Nilesh Khade and Rahul Shivaji Adnaik Department of Pharmacology, Rajarambapu College of Pharmacy, Kasegaon, Tal. Walwa, Dist. Sangli, Maharashtra, India ABSTRACT Diabetes mellitus is in alarming rise from 40 million to 70 million people by 2025 in India. Drug Utilization studies help to identify the treatment of adherence problems and improve proper drug usage. The present work was undertaken to evaluate the drug utilization pattern of anti-diabetic drugs in DM patients. A prospective observational study was carried out at rural areas nearby to Islampur for a period of 3 months. 90 patients were screened having DM and a structured questionnaire was used to collect data and analysis done. The prevalence was about 6.6% Type I DM and 93.33% of them about 50% patients were in above 50 years of age. Totally 76.66% of patients were on monotherapy and Metformin (Glycomate) was commonly prescribed. In combination therapy, Glibenclamide and Metformin (35.86%) were mostly. Type II DM was treated effectively with both Insulin and Oral hypoglycemic drugs. The average cost of Therapy during the Study was found to be Rs. 100-300/month in 70% of population under study. In the study carried out most of the prescriptions were rational, but further improvement is needed. The choice of drug should be based economic status, associated conditions. Rational prescribing should focus on dose and duration as well as interaction with other medications. Keywords: Drug Utilization, diabetes, questionnaire, monotherapy, prescriptions. INTRODUCTION Diabetes mellitus is a metabolic disorder with common denominator of hyperglycemia, arising from a variety of pathogenic mechanisms. It has emerged as an epidemic both in the developing and developed countries and shows no signs of regression [1]. Diabetes mellitus (DM) is a major health growing problem and an important cause of prolong ill health and early death. It was the sixteen leading cause of global mortality in 1990 [2]. DM is a chronic progressive metabolic disorder characterized by hyperglycemia mainly due to absolute (Type 1 DM) or relative (Type 2 DM) deficiency of insulin hormone. DM virtually affects every system of the body mainly due to metabolic disturbances caused by hyperglycemia [3]. Diabetes results from the failure of the pancreas to produce a sufficient amount of insulin. Hormone that regulates the body's use of glucose is insulin the pancreas produces a sufficient amount of insulin, but if the insulin is blocked from the body's cells and cannot be used. This causes patients to have abnormally high amounts of sugar in their urine and blood. Diagnosing a patient with diabetes is more complicated than measuring the glucose level of urine only one time. The diagnosis involves several hours of glucose-tolerance tests (GTT). These tests measure the rate in which sugar is removed from the bloodstream and after the test are complete, high glucose level indicates insufficient insulin and the patient is diagnosed with diabetes [4] 33

Currently, India leads the world with the largest number of diabetic subjects and this is expected to further rise in the coming years. Given the high prevalence of diabetes in Indians with over 50 million diabetics already, and the numbers expected to increase to 87 million by the year 2030, this could place considerable burden on the health budgets of this country [5]. The study of prescribing pattern is a component of medical audit that does monitoring and evaluation of the prescribing practice of the prescribers as well as recommends necessary modifications to achieve rational and cost effective medical care [3]. Therefore, drug utilization studies, which evaluate and analyze drug therapy are more meaningful, and observe the prescribing attitude of physicians with the aim to provide drugs rationally. Keeping all these facts in consideration, the present study was designed to analyze the prescribing patterns of antidiabetic drugs at Nearby Villages to Islampur, Sangli Dist, India. MATERIALS AND METHODS A randomized observational household study was carried out on 90 diabetic patients of both type I and II was conducted for a period of 3 months from Jan to March 2015 at Nearby Villages to Islampur, Sangli Dist, India. The major occupation being agriculture. Patients were adults and geriatrics of both the genders and different BMI. Door to door visits were made by the investigators with the help of health workers. A structured questionnaire was explained in the vernacular language. Demographic data, detailed medical history, medications for diabetes mellitus, questions regarding lifestyle, dietary pattern, and exercise programme were recorded in the study proforma. Subsequent visits were done at monthly intervals. These data were used for evaluation. RESULTS AND DISCUSSION Data of 90 diabetic patients was collected and studied the prescription pattern. Most of the patients belong to the age group above 60 years (50%) followed by 40-60 years (40%). They had Type 2 Diabetes mellitus. Out of 90 patients who were being studied, 76.66% patients were on mono therapy. The patients were either on monotherapy consisting of Insulin, metformin or sulphonyl urea or they were on combination therapy. 6% patients were taking insulin among whom bood glucose levels within range. We found that the most commonly prescribed drug in the patients was glycomate (26.66%), Insulin (6 %), metformin with sulphonyl urea (20%), The most effective combination of drugs in combination therapy category was insulin & metformin (14.66%). We found out that most people didn t monitor their glucose levels regularly and most weren t doing or advised any form of exercise and diet control. These are important for glycemic control in Type 2 diabetic patients. Hence the patients should be counseled about the importance of diet control and exercise. Also they should be advised to monitor their blood glucose levels regularly so that appropriate drug regimen should be prescribed according to their needs. We also determined that combination therapy isn t being prescribed much although it is found in literature that most experts prefer combination therapy over monotherapy [7-9]. Therefore, the doctors should seek alternatives when they see that their target for glucose level within normal range is not being met. Fig 1 & 2 : Distribution of the diabetic patients according to sex and age (n=90) 34

Fig 3: Distribution of the diabetic patients according Type of Diabetes (n=90) Fig 4: Anti- diabetic drug Therapy pattern among the study population Fig 5: Class of Antidiabetics used among the study population 35

Fig 6: Dosage form of Antidiabetics used among the study population Fig 7: Cost of Therapy during the Study CONCLUSION Diabetes should be managed properly to enhance the quality of life of the patient. In the study carried out most of the prescriptions were rational, but further improvement is needed. The choice of drug should be based economic status, associated conditions. Rational prescribing should focus on dose and duration as well as interaction with other medications. This can be done by prescribing a proper drug regimen consisting of hypoglycemic agents as well as diet control and exercise. Efforts from both patients and the physician should be made to meet the target glucose levels and have a better and healthy life. REFERENCES [1] A. C. Powers, D. D Alessio, In: Brunton LL, Chabner BA, Knollman BC, editors. Goodman and Gilman s The Pharmacological Basis of Therapeutics D. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia, 12th ed, (McGraw-Hill, New York, 2011) 1237. [2] S. Arunachalam, S. Gunasekaran, Diabetes research in india and china today: From Literature-based mapping to health-care policy, 1999. [3] L. D. Roberts, D. G. Hassall, D. A. Winegar, J. N. Haselden, A. W. Nicholls, J. L. Griffin, J. Diabetes Metab. Disord., 2009, 1, 115. 36

[4] H. Sun, T. Jiang, S. Wang, H. Bing, Y. Zhang, D. Piao, Y. Chong, Na W, HanP, The effect of LXR(, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acids diet-induced insulin resistance, 26 Oct 2013. [5] D. N. Parchwani, A. A. Upadhyah, Int. J. Med. Sci. Pub. Health, 2012, 1, 59-70. [6] N. Gupta, D. Sharma, S. K. Garg, V. K. Bhargava, Ind. J. Pharmacol, 1997, 29, 411-415. [7] L. Kuritzky, G. P. Samraj, Diabetes Ther., 2011, 2 (3), 162-177. [8] http://formularyjournal.modernmedicine.com/formulary-journal/content/combination-therapy-more-effectivemetformin-alone-treating-youth-type-2-d?page=full [9] S. Naveed, A. Siddiqui, A. Rais, S. Usman, S. Irma, Z. S. Wasiqa, MJPMS Mintage J. Med. Pharm. Sci., 2014, 3, 11-14. 37